CDER Issues Staff Manual on the Newly Identified Safety Signal Process By Sam | May 5, 2020 CDER laid out how it will review newly identified safety signals (NISS) for marketed drugs, in a new Manual of Policies and Procedures (MAPP). Source: Drug GMP Report Posted in Drug GMP Report